Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals,...

FDA Recall #D-0550-2023 — Class II — March 16, 2023

Recall #D-0550-2023 Date: March 16, 2023 Classification: Class II Status: Ongoing

Product Description

Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52

Reason for Recall

CGMP Deviations

Recalling Firm

Northwind Pharmaceuticals LLC — Indianapolis, IN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

33 bottles

Distribution

Nationwide with the United States

Code Information

Lot#: F107752201, Exp. Date 05/31/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls